Clinical Trials · NCT04763564
Efficacy of Liraglutide Therapy in Patients With IPAA
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- University of North Carolina, Chapel Hill
- Enrollment
- 8
- Start date
- Mar 2022
- Locations
- 1 site, United States
- Primary endpoint
- Mean % Reduction of Bowel Frequency in Percent of the Mean 7-day Bowel Frequency After 4 Weeks of Therapy on Liraglutide vs Placebo Compared to Baseline .